BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 90 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $50,000 | -21.9% | 1,100 | -31.2% | 0.01% | -44.4% |
| Q2 2016 | $64,000 | +14.3% | 1,600 | 0.0% | 0.01% | +12.5% |
| Q1 2016 | $56,000 | 0.0% | 1,600 | +23.1% | 0.01% | -11.1% |
| Q4 2015 | $56,000 | +33.3% | 1,300 | +18.2% | 0.01% | +50.0% |
| Q4 2014 | $42,000 | +7.7% | 1,100 | 0.0% | 0.01% | +20.0% |
| Q3 2014 | $39,000 | – | 1,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 73,649 | $3,646,000 | 2.32% |
| Stonepine Capital Management, LLC | 59,878 | $2,965,000 | 1.60% |
| NORTHPOINTE CAPITAL LLC | 109,644 | $5,428,000 | 0.57% |
| Elk Creek Partners, LLC | 145,406 | $7,199,000 | 0.47% |
| TFS CAPITAL LLC | 18,208 | $901,000 | 0.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 161,671 | $8,004,000 | 0.35% |
| Ativo Capital Management LLC | 19,592 | $970,000 | 0.26% |
| Matarin Capital Management, LLC | 57,034 | $2,823,753,000 | 0.26% |
| ISTHMUS PARTNERS, LLC | 16,505 | $817,000 | 0.24% |
| Stanley-Laman Group, Ltd. | 12,546 | $621,000 | 0.17% |